...
首页> 外文期刊>In vivo. >Expression of cyclin-dependent kinases inhibitors p21(WAF1) and p27(KIP1) in benign, premalignant and malignant laryngeal lesions. correlation with cell cycle regulatory proteins.
【24h】

Expression of cyclin-dependent kinases inhibitors p21(WAF1) and p27(KIP1) in benign, premalignant and malignant laryngeal lesions. correlation with cell cycle regulatory proteins.

机译:细胞周期蛋白依赖性激酶抑制剂p21(WAF1)和p27(KIP1)在良性,恶性和恶性喉病变中的表达。与细胞周期调节蛋白的相关性。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Cell cycle progression and transition of cells from the first gap phase (G1) to the DNA replication phase (S) depend on a finely tuned balance between the levels of cyclins, cyclin-dependent kinases (CDKs) and cyclin-dependent kinase inhibitors (CDKIs). MATERIALS AND METHODS: We analyzed 57 squamous cell invasive carcinomas of the larynx, 10 in situ carcinomas, 56 cases of dysplasia, 11 papillomas and 26 keratosis. We investigated: a) the immunohistochemical expression of CDKIs, p21 and p27, b) any possible relation between normal and abnormal immunoprofiles of these proteins and p53 protein and proliferation status as determined by the expression of Ki67 and PCNA, and c) their presence in pre-malignant and malignant laryngeal lesions. RESULTS: Expression of p21 and p27 was observed in 58.9% and 89.5% of the laryngeal carcinomas, respectively. High levels of p21 were significantly correlated with increased cyclin D (p=0.001), cyclin E (p<0.001) and Ki67 (p<0.001), while increased expressionlevels of p27 were associated with p53 accumulation (p=0.02) and with increased proliferation status as expressed by Ki67 (p=0.05). CONCLUSION: Due to the increased expression levels of CDKIs in laryngeal carcinomas, we suggest the existence of a mechanism by which tumor cells tolerate the inhibitory effect of these proteins on cell cycle progression.
机译:背景:细胞周期的进展以及细胞从第一个缺口阶段(G1)到DNA复制阶段(S)的转变取决于细胞周期蛋白,细胞周期蛋白依赖性激酶(CDK)和细胞周期蛋白依赖性激酶抑制剂水平之间的微调平衡(CDKI)。材料与方法:我们分析了57例喉鳞状细胞浸润癌,10例原位癌,56例不典型增生,11例乳头状瘤和26例角化病。我们研究了:a)CDKIs,p21和p27的免疫组织化学表达,b)这些蛋白和p53蛋白的正常和异常免疫谱与增殖状态之间的任何可能关系,如通过Ki67和PC​​NA的表达所确定,以及c)它们的存在喉癌前病变和恶性病变。结果:喉癌中p21和p27的表达分别为58.9%和89.5%。高水平的p21与细胞周期蛋白D(p = 0.001),细胞周期蛋白E(p <0.001)和Ki67(p <0.001)的增加显着相关,而p27表达水平的增加与p53的积累(p = 0.02)和增加相关。由Ki67表示的增殖状态(p = 0.05)。结论:由于CDKIs在喉癌中的表达水平升高,我们建议存在一种机制,使肿瘤细胞能够耐受这些蛋白质对细胞周期进程的抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号